[Non-immunologic factor: immunosuppressive drug-induced nephrotoxicity]

Tatsuya Nakatani1, Toshihiro Asai

  • 1Department of Urology, Osaka City University Graduate School of Medicine.

Insights

Magnesium (Mg) supplementation significantly reduces cyclosporine A (CsA)-induced kidney damage by inhibiting inflammatory cell infiltration and fibrosis. This effect appears independent of the renin-angiotensin system, offering a novel therapeutic strategy for immunosuppressant nephrotoxicity.

Area of Science:

  • Nephrology
  • Immunology
  • Pharmacology

Context:

  • Immunosuppressant-induced nephrotoxicity is a major cause of long-term kidney graft loss.
  • Cyclosporine A (CsA) is a common immunosuppressant associated with significant nephrotoxicity.
  • Magnesium (Mg) deficiency exacerbates CsA nephrotoxicity, but the underlying mechanisms require elucidation.

Purpose:

  • To investigate the protective mechanisms of Mg supplementation against CsA-induced nephrotoxicity.
  • To examine the role of the renin-angiotensin system (RAS) in CsA nephrotoxicity and Mg's potential modulation of it.
  • To elucidate the impact of Mg on CsA-induced interstitial mononuclear cell infiltration and subsequent tubulointerstitial fibrosis.

Summary:

  • CsA administration in rats led to impaired renal function, increased tubulointerstitial fibrosis, and elevated expression of chemoattractant proteins (osteopontin, MCP-1).
  • Mg supplementation ameliorated CsA-induced renal dysfunction and fibrosis, significantly reducing inflammatory cell infiltration.
  • Angiotensin-converting enzyme inhibitor (ACEI) showed limited protective effects, suggesting Mg's benefits are largely independent of the RAS.

Impact:

  • Mg supplementation effectively prevents CsA-induced nephrotoxicity by inhibiting inflammatory cell influx and fibrosis, independent of the RAS.
  • These findings highlight Mg as a potential therapeutic agent to mitigate long-term kidney damage in patients receiving CsA.
  • Understanding this mechanism provides a basis for developing novel strategies to improve kidney graft survival and patient outcomes.

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...